These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 15772231)

  • 21. Atherosclerotic renovascular disease and progressive renal failure.
    Rimmer JM; Gennari FJ
    Ann Intern Med; 1993 May; 118(9):712-9. PubMed ID: 8460859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of the patient with atherosclerotic renal artery stenosis. New information from randomized trials.
    Plouin PF; Alanore AL
    Nephrol Dial Transplant; 1999 Jul; 14(7):1623-6. PubMed ID: 10435867
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition.
    Losito A; Errico R; Santirosi P; Lupattelli T; Scalera GB; Lupattelli L
    Nephrol Dial Transplant; 2005 Aug; 20(8):1604-9. PubMed ID: 15870215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ischemic renal disease: revascularization or conservative treatment?].
    Rodríguez Jornet A; Ibeas J; Ribera L; Real J; Perendreu J; Falcó J; Vallespín J; Allegué N; Giménez Gaibar A; García García M
    Nefrologia; 2005; 25(3):258-68. PubMed ID: 16053007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management.
    Plouin PF
    Am J Kidney Dis; 2003 Nov; 42(5):851-7. PubMed ID: 14582030
    [No Abstract]   [Full Text] [Related]  

  • 26. Arteriosclerotic renal artery stenosis: conservative versus interventional management.
    Haller C
    Heart; 2002 Aug; 88(2):193-7. PubMed ID: 12117859
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New perspectives for patients at risk for atherosclerosis. The importance of ACE inhibitors in cardiovascular prevention].
    Landgraf W; Klein HH
    Pharm Unserer Zeit; 2003; 32(1):36-44. PubMed ID: 12577759
    [No Abstract]   [Full Text] [Related]  

  • 29. Is the 'wait-and-see' approach justified in atherosclerotic renal artery stenosis?
    Scoble JE
    Nephrol Dial Transplant; 1995; 10(5):588-9. PubMed ID: 7566563
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?
    Böhm M
    Am J Cardiol; 2007 Aug; 100(3A):38J-44J. PubMed ID: 17666197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enalapril-induced renal artery thrombosis in unilateral renal artery stenosis.
    Kothari SS; Sharma S; Sharma M; Saxena A
    Indian Heart J; 1997; 49(2):192-4. PubMed ID: 9231557
    [No Abstract]   [Full Text] [Related]  

  • 32. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Ruilope LM
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atherosclerotic renal vascular disease. Diagnosis and treatment.
    Sheps SG; Bernatz PE
    Geriatrics; 1968 Feb; 23(2):169-84. PubMed ID: 4865638
    [No Abstract]   [Full Text] [Related]  

  • 34. When should atheromatous renal artery stenosis be considered? A guide for the general physician.
    Main J
    Clin Med (Lond); 2003; 3(6):520-5. PubMed ID: 14703030
    [No Abstract]   [Full Text] [Related]  

  • 35. ACE inhibition in stable coronary artery disease.
    McCullough C
    N Engl J Med; 2005 Mar; 352(9):937-9; author reply 937-9. PubMed ID: 15751129
    [No Abstract]   [Full Text] [Related]  

  • 36. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction.
    Jose P; Tomson C; Skali H; Rouleau J; Braunwald E; Arnold JM; Cuddy T; Sussex B; Bernstein V; Pfeffer M; Solomon S
    J Am Coll Cardiol; 2006 Apr; 47(8):1725-7. PubMed ID: 16631015
    [No Abstract]   [Full Text] [Related]  

  • 38. [No advantage of the combination of ACE-inhibition and angiotensin receptor blockade in patients with high cardiovascular risk].
    Slagman MC; Waanders F; Navis GJ
    Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2150-1; author reply 2151. PubMed ID: 18924267
    [No Abstract]   [Full Text] [Related]  

  • 39. [The changing etiology and therapeutic situation of atherosclerotic renal artery stenosis].
    Wang F; Wang M; Liu YC; Wang HY
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2762-6. PubMed ID: 16324317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unsuspected renal artery stenosis in peripheral vascular disease.
    Choudhri AH; Cleland JG; Rowlands PC; Tran TL; McCarty M; al-Kutoubi MA
    BMJ; 1990 Nov; 301(6762):1197-8. PubMed ID: 2261558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.